Somanetics (SMTS) Reports Q1 In-Line; Re-affirms Guidance
Somanetics (Nasdaq: SMTS) reports Q1 EPS of $0.10, cents better than the analyst estimate of $0.10. Revenues for the quarter were $11.2 million, versus the consensus of $10.91 million.
Somanetics reaffirms financial guidance for FY09.
Somanetics reaffirms financial guidance for FY09.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Jiayuan.com (DATE) Reports In-Line Q1 EPS of 5c; Guides Q2 Revs
- Flowers Foods, Inc. (FLO) Reports In-Line Q1 EPS; Adjusts FY12 EPS Growth Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
